| Abstrakt: |
A report from Shenyang Pharmaceutical University in Liaoning, China discusses the use of Cu(Ii)-doped mesoporous polydopamine nanoparticles as biodegradable nanoplatforms for photothermal-enhanced multi-mode anti-tumor therapy. The researchers found that these nanoparticles exhibited high photothermal conversion efficiency and stability, making them effective agents for photothermal therapy. The nanoparticles also demonstrated self-enhanced chemodynamic performance and favorable degradability. In in vivo experiments, the researchers observed improved anti-tumor efficacy when using these nanoparticles in combination with doxorubicin. This research provides promising insights into the development of nanoplatforms for cancer therapy. [Extracted from the article] |
